The U.S. Food and Drug Administration approved the first new pain reliever to hit the market in over 20 years. This medication, produced by Vertex Pharmaceuticals Inc VRTX +0.07% , is a non-opioid and therefore non-addictive. The new drug, suzetrigine, will be sold under the brand name Journavx.
Unlike opioids, Journavx blocks pain signals in the peripheral nervous system, not in the brain, so it does not create the same pleasurable effects usually felt with opioids and which often leads to dependence or addiction.
Buzz
At 420 Intel, we cover cannabis legalization news throughout the world, offer reliable information for cannabis business owners, detail technological advances that impact the marijuana industry, cover marijuana rallies from across the globe, and everything in between.
- Buzz
- 6 March 2025
Compound mimics cannabis for pain relief without the side effects: Mouse study points to effective opioid alternative
Treatment for chronic pain still relies heavily on opioids. While effective, they are highly...
- Buzz
- 7 March 2025
Cannabis-Derived Compound Could Provide Nonaddictive Pain Relief
Researchers at Washington University (WashU) School of Medicine in St. Louis and Stanford...
- Buzz
- 1 April 2025
Company claims to have made first non-addictive cannabis painkiller
Acannabis-derived drug is the first non-addictive and clinically-proven painkiller made using the...